Chemoinformaics analysis of epi-zanthocadinanine B
Molecular Weight | 583.769 | nRot | 6 |
Heavy Atom Molecular Weight | 538.409 | nRig | 36 |
Exact Molecular Weight | 583.33 | nRing | 7 |
Solubility: LogS | -7.381 | nHRing | 2 |
Solubility: LogP | 7.552 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 88 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 43 | No. of Aromatic Carbocycles | 3 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 45 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 37 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 16 |
No. of Oxygen atom | 5 | No. of Arom Bond | 17 |
nHA | 6 | APOL | 96.9057 |
nHD | 0 | BPOL | 55.5343 |
QED | 0.271 |
Synth | 4.653 |
Natural Product Likeliness | 1.866 |
NR-PPAR-gamma | 0.006 |
Lipinski | Rejected |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 1 |
Pgp-sub | 0.95 |
HIA | 0.002 |
CACO-2 | -4.933 |
MDCK | 0.0000185 |
BBB | 0.02 |
PPB | 0.947291 |
VDSS | 2.069 |
FU | 0.00471543 |
CYP1A2-inh | 0.121 |
CYP1A2-sub | 0.934 |
CYP2c19-inh | 0.807 |
CYP2c19-sub | 0.941 |
CYP2c9-inh | 0.306 |
CYP2c9-sub | 0.919 |
CYP2d6-inh | 0.312 |
CYP2d6-sub | 0.931 |
CYP3a4-inh | 0.819 |
CYP3a4-sub | 0.924 |
CL | 11.395 |
T12 | 0.014 |
hERG | 0.232 |
Ames | 0.105 |
ROA | 0.232 |
SkinSen | 0.243 |
Carcinogencity | 0.408 |
EI | 0.006 |
Respiratory | 0.589 |
NR-Aromatase | 0.88 |
Antiviral | Yes |
Prediction | 0.923569 |